Eugene Rozelman

Eugene Rozelman is an experienced investment banking professional specializing in biotechnology and specialty pharmaceuticals, currently serving as Managing Director and Head of Biotechnology and Spec Pharma Investment Banking at Canaccord Genuity Group Inc. since March 2010. Prior roles include Director of Healthcare Investment Banking at HSBC from 2006 to 2009, Vice President of Healthcare Investment Banking at Wells Fargo from 2003 to 2006, and Senior Associate in Healthcare Investment Banking at Robertson Stephens from 2001 to 2002. Eugene holds an MBA in Finance & Accounting from NYU Stern School of Business and a BA in Biology from New York University, complemented by a foundational education at Stuyvesant High School.